Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Model choice for teicoplanin kinetics in man.

A Danese1, A Bernareggi, R Rosina

  • 1Merrell-Dow Research Institute, Gerenazno (VA), Italy.

European Journal of Drug Metabolism and Pharmacokinetics
|January 1, 1991
PubMed
Summary

Teicoplanin exhibits linear pharmacokinetics in humans. A three-exponential model adequately describes Teicoplanin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Silicate clouds and a circumplanetary disk in the YSES-1 exoplanet system.

Nature·2025
Same author

Obstetrical Events Support Team (OEST): Preventing harm, reducing costs from neonatal brain injury.

Irish medical journal·2025
Same author

Health behaviours of 17- to 19-year olds in North East England: assessing adherence to current recommendations for young people at the adolescent-adult boundary.

Perspectives in public health·2025
Same author

SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients.

Clinical radiology·2025
Same author

Return to Activities of Daily Living after Breast Cancer Surgery: An Observational Prospective Questionnaire-Based Study of Patients Undergoing Mastectomy with or without Immediate Reconstruction.

The breast journal·2023
Same author

Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK.

Psychological medicine·2022

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Pharmacokinetics

Background:

  • Teicoplanin is a long half-life antibiotic with a complex elimination profile.
  • Understanding Teicoplanin's pharmacokinetic behavior is crucial for optimizing therapeutic dosing.

Purpose of the Study:

  • To evaluate the pharmacokinetic profile of Teicoplanin in healthy volunteers.
  • To determine the optimal mathematical model for describing Teicoplanin plasma concentration-time data.
  • To assess the linearity of Teicoplanin pharmacokinetics within a specific dosage range.

Main Methods:

  • A pharmacokinetic study involving healthy volunteers administered intravenous Teicoplanin at 15, 20, and 25 mg/Kg.
  • Plasma concentration-time data were analyzed using polyexponential equations (2-5 terms) fitted with PCNONLIN software.
  • Statistical criteria including Akaike, Gallant, and F-ratio tests were employed to assess model fit.

Main Results:

  • A four-exponential equation provided the best fit for most Teicoplanin plasma concentration-time datasets.
  • Key pharmacokinetic parameters (AUC, V, Vss, CL) derived from tri- and four-exponential models showed no significant differences.
  • Teicoplanin pharmacokinetics demonstrated linearity across the studied dose range.

Conclusions:

  • While additional exponential terms improve curve fitting, a three-exponential model is sufficient for clinical pharmacokinetic analysis of Teicoplanin.
  • The linearity of Teicoplanin pharmacokinetics simplifies dose adjustments in clinical practice.

Related Experiment Videos